Table 1.

Demographics and risperidone exposures in study cohort

Characteristic	N = 371
Age at commencement of risperidone, years	7.8 (5.9–10.2)
Sex
Male	271 (73.0)
Female	100 (27.0)
Race
White	308 (83.0)
African–American	47 (12.7)
Asian/Pacific Islander	8 (2.2)
Native American	2 (0.5)
Unknown	6 (1.6)
Ethnicity
Non-Hispanic	356 (96.0)
Hispanic	8 (2.2)
Unknown	7 (1.9)
Risperidone starting dose, mg/day	0.50 (0.37–1.00)

Data are presented as n (%) or median (interquartile range)